Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin Plus Irinotecan vs Irinotecan in Pediatric Refractory Solid Tumors
NCT00057473Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2003
- Primary completion
- Feb 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in solid tumor, sponsored by Bristol Myers Squibb. Started Feb 2003; status: completed.
02
Drugs
carboplatin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00057473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057473.